New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

Oncaspar (pegaspargase) is a long-acting prescription injection medicine used for people with a type of blood cancer known as acute lymphoblastic leukemia (ALL). It is also approved specifically for ...

Credit: Getty Images ALL is the most common childhood cancer, and cases are rising. Find out why this trend is paired with a remarkable 90% survival rate, and what public health action is needed next.

Please provide your email address to receive an email when new articles are posted on . A targeted therapy/immunotherapy combination improved outcomes vs. standard treatment for newly diagnosed ...

When hospital staff handed 5-year-old Grant Lawson a custom “Thor” action figure, it wasn’t just a toy — it was a reflection of his own strength. Grant was diagnosed with B-cell acute lymphoblastic ...

At the recent American Society of Hematology annual meeting, researchers presented preclinical data examining how transdifferentiation between hematopoietic lineages -- driven by LMO2 expression and ...

Acute Lymphocytic Leukemia (ALL) is a serious type of cancer that affects the blood and bone marrow. It moves very quickly, meaning it needs fast and strong treatment. In ALL, the body starts making ...